跳到正文
原文
NEJM· Thomas Powles Enrique Grande Giuseppe Simone Alfonso Gómez de Liaño Marco Maruzzo Pedro Isaacsson Velho Eiji Kikuchi Toan Quang Vu Lazar Popovic Timuçin Çil Gwenaelle Gravis Robert Radkowski Luis Raúl Novelo Hernández Hernán Javier Cutuli Aristotelis Bamias Thomas Bauernhofer Michel Pavic Yoon Ji Choi Chao-Hsiang Chang Hiroshi Kitamura Jonathan E. Rosenberg Jacqui Rowbottom Svetlana Ho Ashok Gupta and Alexandra Drakakithe VOLGA Investigators*·· 25 天前AI 评分31

Durvalumab、Tremelimumab 联合 Enfortumab Vedotin 治疗肌层浸润性膀胱癌

Durvalumab, Tremelimumab, and Enfortumab Vedotin in Muscle-Invasive Bladder Cancer

AI 导读

NEJM 发表 Durvalumab、Tremelimumab 与 Enfortumab Vedotin 联合方案治疗肌层浸润性膀胱癌的研究。该文以 Ahead of Print 形式在线发布,具体疗效与安全性数据尚未在本文中披露。

来源:NEJM · nejm.org